4 reports

  • DORMANT PRODUCTS, H1 2018 (CONTD..1), H1 2018

As of March 2003, the drug candidate was in preclinical stage for west Nile virus infections, Japanese encephalitis, dengue fever, yellow fever, St Louis encephalitis, Murray valley and Banzai viruses.

  • Pancreatic Cancer
  • Therapy
  • Vaccine
  • Canada
  • Hemispherx Biopharma, Inc.

Louis encephalitis, yellow fever, Murray valley, and Banzai viruses.

  • Biopharmaceutical
  • Pancreatic Cancer
  • United States
  • Product Initiative
  • Hemispherx Biopharma, Inc.

Louis encephalitis, yellow fever, Murray valley, and Banzai viruses.

  • Chemotherapy
  • Pancreatic Cancer
  • United States
  • Company
  • Product Initiative

Louis encephalitis, yellow fever, Murray valley, and Banzai viruses.

  • Cancer
  • Pancreatic Cancer
  • United States
  • Company
  • Product Initiative